Home > > > > Report Detail

Global Vaccines Market: Industry Size, Growth, Analysis and Forecast to 2025

Publisher Name :
Date: 03-Jun-2019
No. of pages: 220

The global vaccines market size is expected to exceed US$ 48 Billion by the year–end of 2025.

“Global Vaccines Market: Industry Size, Growth, Analysis and Forecast to 2025” presents an in–depth assessment of the global vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up–to–date industry data on the actual market situation and future outlook for the global vaccines market. The report includes historical data from 2015 to 2018 and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the global vaccines market. The report explores a detailed analysis of the top 42 vaccines market value assessment globally from 2015 to 2018 and forecasts to 2025.

Additionally, the report includes an assessment of promising vaccines in clinical development by major companies. Key trends in terms of collaboration, merger & acquisitions, partnerships, distribution, exclusive and licensing agreement are analyzed with details. The report also explores the detailed description of growth drivers and inhibitors of the global vaccines market.

The report concludes with the profiles of major players in the global vaccines market. The key market players are evaluated on various parameters such as business overview, vaccines portfolios, promising vaccines in the clinical development, vaccines market value analysis and recent development.

Long–term Growth Projection:


  • Merck acquired Immune Design in 2019

  • Shingrix is set to achieve blockbuster vaccine status in 2019

  • Prevnar / Prevnar 13 has captured the highest market share of the global vaccines market

  • With a market value of more than US$ 7 billion, GSK led the global vaccines market in 2018


Top 42 Vaccines Covered Under This Report Are:


  •     Prevnar / Prevnar 13

  •     Gardasil / Gardasil 9

  •     Vaxigrip

  •     Fluzone

  •     Flublok

  •     Varivax

  •     Menactra

  •     Proquad

  •     Pneumovax 23

  •     Fluarix/FluLaval

  •     Havrix/Twinrix/Engerix–B

  •     Priorix, Priorix Tetra, Varilrix

  •     M–M–R II

  •     Adacel

  •     Boostrix

  •     Bexsero

  •     Menveo

  •     Cervarix

  •     Trumenba

  •     Shingrix

  •     Pentacel, Pentaxim, Imovax, Hexaxim

  •     Rotateq

  •     Zostavax

  •     Rotarix

  •     Synflorix

  •     Pediarix,Infanrix

  •     Ticovac

  •     Biken Ha

  •     Tetrabik

  •     Mearubik

  •     Varicella (MTP)

  •     Jebik V

  •     Flumist/Fluenz

  •     Bio Thrax

  •     Dukoral

  •     Ixiaro

  •     In Live

  •     HeaLive

  •     BiLive

  •     Anflu

  •     EasySix

  •     Imvamune


The major companies dominating this market for its products, services, and continuous product developments are:


  •     Sanofi Pasteur

  •     GlaxoSmithKline (GSK)

  •     Merck

  •     Pfizer

  •     AstraZeneca

  •     Mitsubishi Tanabe Pharma

  •     Emergent Biosolutions

  •     Astellas Pharma Inc

  •     Valneva

  •     Seqirus

  •     Bavarian Nordic

  •     Sinovac

  •     Panacea Biotec

  •     Bharat Biotech

  •     Serum Institute of India

  •     Biological E. Limited


The Latest Industry Data Included in this Report:


  • Global Vaccines Market Size & Analysis (2015 – 2025)

  • Market Share Analysis of Global Vaccines Market (%),2015 – 2025

  • Global Vaccines Market Share, By Brand

  • Global Vaccines Market Share, By Company

  • Global Top 42 Vaccines Market Assessment & Opportunity (Value),2015 – 2025

  • Major Companies Vaccines Market Value Analysis & Forecast

  • Promising Vaccines in Clinical Development by Major Companies

  • Detailed Vaccines Portfolio of the Major Companies

  • Major Deals in the Global Vaccines Market

  • Key Market Drivers and Inhibitors of the Global Vaccines Market

  • Major Companies Analysis


The Report Answers the Following Questions about the Global Vaccines Market:


  • What is the size of the global vaccines market during 2015–2025?

  • What will be the revenue generated by each vaccine during the forecast period?

  • Which vaccine provides the highest market share?

  • What are the leading companies dominating the global vaccines market? What is the share of these companies in the global vaccines market?

  • How will the industry evolve during the forecast period 2019 – 2025?

  • What are the key drivers and inhibitors in the current market?

  • What is the key development implemented by the leading players to stand out in this market?

  • Who are the key players in this market space?

Global Vaccines Market: Industry Size, Growth, Analysis and Forecast to 2025

Table of Contents

1. Executive Summary

2. Global Vaccines Market Size & Analysis (2015 – 2025)

3. Market Share Analysis of Global Vaccines Market (%),2015 – 2025
3.1 Global Vaccines Market Share, By Brand
3.2 Global Vaccines Market Share, By Company

4. Key Drivers and Inhibitors of the Global Vaccines Market
4.1 Market Drivers
4.2 Market Inhibitors

5. Global Top 42 Vaccines Market Assessment & Opportunity (Value),2015 – 2025
5.1 Prevnar / Prevnar 13
5.2 Gardasil / Gardasil 9
5.3 Vaxigrip
5.4 Fluzone
5.5 Flublok
5.6 Varivax
5.7 Menactra
5.8 Proquad
5.9 Pneumovax 23
5.10 Fluarix/FluLaval
5.11 Havrix/Twinrix/Engerix–B
5.12 Priorix, Priorix Tetra, Varilrix
5.13 M–M–R II
5.14 Adacel
5.15 Boostrix
5.16 Bexsero
5.17 Menveo
5.18 Cervarix
5.19 Trumenba
5.20 Shingrix
5.21 Pentacel, Pentaxim, Imovax, Hexaxim
5.22 Rotateq
5.23 Zostavax
5.24 Rotarix
5.25 Synflorix
5.26 Pediarix,Infanrix
5.27 Ticovac
5.28 Biken Ha
5.29 Tetrabik
5.30 Mearubik
5.31 Varicella (MTP)
5.32 Jebik V
5.33 Flumist/Fluenz
5.34 Bio Thrax
5.35 Dukoral
5.36 Ixiaro
5.37 In Live
5.38 HeaLive
5.39 BiLive
5.40 Anflu
5.41 EasySix
5.42 Imvamune
5.43 Other Vaccines

6. Major Deals in Global Vaccines Market
6.1 Merger & Acquisitions
6.2 Collaboration Deal
6.3 Licensing Agreement
6.4 Exclusive Agreement
6.5 Distribution Agreement
6.6 Partnerships

7. Key Companies Analysis
7.1 Sanofi Pasteur
7.1.1 Business Overview
7.1.2 Vaccines Portfolio
7.1.3 Vaccines Market Value Analysis & Forecast
7.1.4 Promising Vaccines in Clinical Development
7.1.5 Recent Development
7.2 GlaxoSmithKline (GSK)
7.2.1 Business Overview
7.2.2 Vaccines Portfolio
7.2.3 Vaccines Market Value Analysis & Forecast
7.2.4 Promising Vaccines in Clinical Development
7.2.5 Recent Development
7.3 Merck
7.3.1 Business Overview
7.3.2 Vaccines Portfolio
7.3.3 Vaccines Market Value Analysis & Forecast
7.3.4 Promising Vaccines in Clinical Development
7.3.5 Recent Development
7.4 Pfizer
7.4.1 Business Overview
7.4.2 Vaccines Portfolio
7.4.3 Vaccines Market Value Analysis & Forecast
7.4.4 Promising Vaccines in Clinical Development
7.4.5 Recent Development
7.5 AstraZeneca
7.5.1 Business Overview
7.5.2 Vaccines Portfolio
7.5.3 Vaccines Market Value Analysis & Forecast
7.5.4 Recent Development
7.6 Mitsubishi Tanabe Pharma
7.6.1 Business Overview
7.6.2 Vaccines Portfolio
7.6.3 Vaccine Market Value Analysis & Forecast
7.6.4 Promising Vaccines in Clinical Development
7.6.5 Recent Development
7.7 Emergent Biosolutions
7.7.1 Business Overview
7.7.2 Vaccines Portfolio
7.7.3 Vaccine Market Value Analysis & Forecast
7.7.4 Promising Vaccines in Clinical Development
7.7.5 Recent Development
7.8 Astlellas Pharma Inc
7.8.1 Business Overview
7.8.2 Vaccines Portfolio
7.8.3 Vaccines Market Value Analysis & Forecast
7.8.4 Recent Development
7.9 Valneva
7.9.1 Business Overview
7.9.2 Vaccines Portfolio
7.9.3 Vaccines Market Value Analysis & Forecast
7.9.4 Promising Vaccines in Clinical Development
7.9.5 Recent Development
7.10 Seqirus
7.10.1 Business Overview
7.10.2 Vaccines Portfolio
7.10.3 Vaccine Market Value Analysis & Forecast
7.10.4 Promising Vaccines in Clinical Development
7.10.5 Recent Development
7.11 Bavarian Nordic
7.11.1 Business Overview
7.11.2 Vaccines Portfolio
7.11.3 Vaccine Market Value Analysis & Forecast
7.11.4 Promising Vaccines in Clinical Development
7.11.5 Recent Development
7.12 Sinovac
7.12.1 Business Overview
7.12.2 Vaccines Portfolio
7.12.3 Vaccine Market Value Analysis & Forecast
7.12.4 Promising Vaccines in Clinical Development
7.12.5 Recent Development
7.13 Panacea Biotec
7.13.1 Business Overview
7.13.2 Vaccines Portfolio
7.13.3 Vaccine Market Value Analysis & Forecast
7.13.4 Promising Vaccines in Clinical Development
7.13.5 Recent Development
7.14 Bharat Biotech
7.14.1 Business Overview
7.14.2 Vaccines Portfolio
7.14.3 Promising Vaccines in Clinical Development
7.14.4 Recent Development
7.15 Serum Institute of India
7.15.1 Business Overview
7.15.2 Vaccines Portfolio
7.15.3 Promising Vaccines in Clinical Development
7.15.4 Recent Development
7.16 Biological E. Limited
7.16.1 Business Overview
7.16.2 Vaccines Portfolio
7.16.3 Promising Vaccines in Clinical Development
7.16.4 Recent Development

List of Tables

Table 3–1: Global Vaccines Market Share & Y–o–Y Growth By Brand (Percent), 2015 – 2018
Table 3–2: Global Vaccines Market Share & Y–o–Y Growth By Brand Forecast (Percent), 2019 – 2025
Table 3–3: Global  Vaccines Market Share & Y–o–Y Growth By Company Forecast (Percent), 2015 – 2018
Table 3–4: Global Vaccines Market Share & Y–o–Y Growth By Company Forecast (Percent), 2019 – 2025
Table 6–1: Merger & Acquisitions in the Global Vaccines Market
Table 6–2: Collaboration Deal in the Global Vaccines Market
Table 6–3: Licensing Agreement in the Global Vaccines Market
Table 6–4: Exclusive Agreement in the Global Vaccines Market
Table 6–5: Distribution Agreement in the Global Vaccines Market
Table 6–6: Partnerships in the Global Vaccines Market
Table 7–1: Sanofi Promising Vaccines in Clinical Development
Table 7–2: GSK Promising Vaccines in Clinical Development
Table 7–3: Merck Promising Vaccines in Clinical Development
Table 7–4: Pfizer Promising Vaccines in Clinical Development
Table 7–5: Mitsubishi Tanabe Pharma Promising Vaccines in Clinical Development
Table 7–6: Emergent Biosolutions Promising Vaccines in Clinical Development
Table 7–7: Valneva Promising Vaccines in Clinical Development
Table 7–8: Seqirus Promising Vaccines in Clinical Development
Table 7–9: Bavarian Nordic Promising Vaccines in Clinical Development
Table 7–10: Sinovac Promising Vaccines in Clinical Development
Table 7–11: Panacea Biotec Promising Vaccines in Clinical Development
Table 7–12: Bharat Biotech Promising Vaccines in Clinical Development

List of Figures

Figure 2–1: Global Vaccines Market Size (Million US$),2015 – 2018
Figure 2–2: Global Vaccines Market Size Forecast (Million US$),2019 – 2025
Figure 5–1: Global Prevnar/Prevnar 13 Market Value (Million US$),2015 – 2018
Figure 5–2: Global Prevnar/Prevnar 13 Market Value Forecast (Million US$),2019 – 2025
Figure 5–3: Global Gardasil/Gardasil 9 Market Value (Million US$),2015 – 2018
Figure 5–4: Global Gardasil/Gardasil 9 Market Value Forecast (Million US$),2019 – 2025
Figure 5–5: Global Vaxigrip Market Value (Million US$),2015 – 2018
Figure 5–6: Global Vaxigrip Market Value Forecast (Million US$),2019 – 2025
Figure 5–7: Global Fluzone Market Value (Million US$),2015 – 2018
Figure 5–8: Global Fluzone Market Value Forecast (Million US$),2019 – 2025
Figure 5–9: Global Flublok Market Value & Forecast (Million US$),2018 – 2025
Figure 5–10: Global Varivax Market Value (Million US$),2015 – 2018
Figure 5–11: Global Varivax Market Value Forecast (Million US$),2019 – 2025
Figure 5–12: Global Menactra Market Value (Million US$),2015 – 2018
Figure 5–13: Global Menactra Market Value Forecast (Million US$),2019 – 2025
Figure 5–14: Global Proquad Market Value (Million US$),2015 – 2018
Figure 5–15: Global Proquad Market Value Forecast (Million US$),2019 – 2025
Figure 5–16: Global Pneumovax 23 Market Value (Million US$),2015 – 2018
Figure 5–17: Global Pneumovax 23 Market Value Forecast (Million US$),2019 – 2025
Figure 5–18: Global Fluarix/FluLaval Market Value (Million US$),2015 – 2018
Figure 5–19: Global Fluarix/FluLaval Market Value Forecast (Million US$),2019 – 2025
Figure 5–20: Global Havrix/Twinrix/Engerix–B Market Value (Million US$),2015 – 2018
Figure 5–21: Global Havrix/Twinrix/Engerix–B Market Value Forecast (Million US$),2019 – 2025
Figure 5–22: Global Priorix, Priorix Tetra, Varilrix Market Value (Million US$),2015 – 2018
Figure 5–23: Global Priorix, Priorix Tetra, Varilrix Market Value Forecast (Million US$),2019 – 2025
Figure 5–24: Global M–M–R ll Market Value (Million US$),2015 – 2018
Figure 5–25: Global M–M–R ll Market Value Forecast (Million US$),2019 – 2025
Figure 5–26: Global Adacel Market Value (Million US$),2015 – 2017
Figure 5–27: Global Adacel Market Value Forecast (Million US$),2018 – 2025
Figure 5–28: Global Boostrix Market Value (Million US$),2015 – 2018
Figure 5–29: Global Boostrix Market Value Forecast (Million US$),2019 – 2025
Figure 5–30: Global Bexsero Market Value (Million US$),2015 – 2018
Figure 5–31: Global Bexsero Market Value Forecast (Million US$),2019 – 2025
Figure 5–32: Global Menveo Market Value (Million US$),2015 – 2018
Figure 5–33: Global Menveo Market Value Forecast (Million US$),2019 – 2025
Figure 5–34: Global Cervarix Market Value (Million US$),2015 – 2018
Figure 5–35: Global Cervarix Market Value Forecast (Million US$),2019 – 2025
Figure 5–36: Global Trumenba Market Value (Million US$),2015 – 2018
Figure 5–37: Global Trumenba Market Value Forecast (Million US$),2019 – 2025
Figure 5–38: Global Shingrix Market Value & Forecast (Million US$),2017 – 2018
Figure 5–39: Global Shingrix Market Value & Forecast (Million US$),2019 – 2025
Figure 5–40: Global Pentacel, Pentaxim, Imovax, Hexaxim Market Value (Million US$),2015 – 2018
Figure 5–41: Global Pentacel, Pentaxim, Imovax, Hexaxim Market Value Forecast (Million US$),2018 – 2025
Figure 5–42: Global Rotateq Market Value (Million US$),2015 – 2018
Figure 5–43: Global Rotateq Market Value Forecast (Million US$),2019 – 2025
Figure 5–44: Global Zostavax Market Value (Million US$),2015 – 2018
Figure 5–45: Global Zostavax Market Value Forecast (Million US$),2019 – 2025
Figure 5–46: Global Rotarix Market Value (Million US$),2015 – 2018
Figure 5–47: Global Rotarix Market Value Forecast (Million US$),2019 – 2025
Figure 5–48: Global Synflorix Market Value (Million US$),2015 – 2018
Figure 5–49: Global Synflorix Market Value Forecast (Million US$),2019 – 2025
Figure 5–50: Global Pediarix/Infanrix Market Value (Million US$),2015 – 2018
Figure 5–51: Global Pediarix/Infanrix Market Value Forecast (Million US$),2019 – 2025
Figure 5–52: Global Ticovac Market Value (Million US$),2015 – 2018
Figure 5–53: Global Ticovac Market Value Forecast (Million US$),2019 – 2025
Figure 5–54: Global Biken Ha Market Value (Million US$),2015 – 2018
Figure 5–55: Global Biken Ha Market Value Forecast (Million US$),2019 – 2025
Figure 5–56: Global Tetrabik Market Value (Million US$),2015 – 2018
Figure 5–57: Global Tetrabik Market Value Forecast (Million US$),2019 – 2025
Figure 5–58: Global Mearubik Market Value (Million US$),2015 – 2018
Figure 5–59: Global Mearubik Market Value Forecast (Million US$),2019 – 2025
Figure 5–60: Global Varicella (MTP) Market Value (Million US$),2015 – 2018
Figure 5–61: Global Varicella (MTP) Market Value Forecast (Million US$),2019 – 2025
Figure 5–62: Global Jebik V Market Value (Million US$),2015 – 2018
Figure 5–63: Global Jebik V Market Value Forecast (Million US$),2019 – 2025
Figure 5–64: Global Flumist/Fluenz Market Value (Million US$),2015 – 2018
Figure 5–65: Global Flumist/Fluenz Market Value Forecast (Million US$),2019 – 2025
Figure 5–66: Global Bio Thrax Market Value (Million US$),2015 – 2018
Figure 5–67: Global Bio Thrax Market Value Forecast (Million US$),2019 – 2025
Figure 5–68: Global Dukoral Market Value (Million US$),2015 – 2018
Figure 5–69: Global Dukoral Market Value Forecast (Million US$),2019 – 2025
Figure 5–70: Global Ixiaro Market Value (Million US$),2015 – 2018
Figure 5–71: Global Ixiaro Market Value Forecast (Million US$),2019 – 2025
Figure 5–72: Global In Live Market Value (Million US$),2015 – 2018
Figure 5–73: Global In Live Market Value Forecast (Million US$),2019 – 2025
Figure 5–74: Global HeaLive Market Value (Million US$),2015 – 2018
Figure 5–75: Global HeaLive Market Value Forecast (Million US$),2019 – 2025
Figure 5–76: Global BiLive Market Value (Million US$),2015 – 2018
Figure 5–77: Global BiLive Market Value Forecast (Million US$),2019 – 2025
Figure 5–78: Global Anflu Market Value (Million US$),2015 – 2018
Figure 5–79: Global Anflu Market Value Forecast (Million US$),2019 – 2025
Figure 5–80: Global EasySix Market Value (Million US$),2015 – 2018
Figure 5–81: Global EasySix Market Value Forecast (Million US$),2019 – 2025
Figure 5–82: Global Imvamune Market Value (Million US$),2015 – 2018
Figure 5–83: Global Imvamune Market Value Forecast (Million US$),2019 – 2025
Figure 5–84: Global Other Vaccines Market Value (Million US$),2015 – 2018
Figure 5–85: Global Other Vaccines Market Value Forecast (Million US$),2019 – 2025
Figure 7–1: Sanofi Pasteur Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 7–2: Sanofi Pasteur Vaccines Market Value Analysis (Million US$),2019 – 2025
Figure 7–3: GSK Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 7–4: GSK Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025
Figure 7–5: Merck Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 7–6: Merck Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025
Figure 7–7: Pfizer Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 7–8: Pfizer Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025
Figure 7–9: AstraZeneca Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 7–10: AstraZeneca Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025
Figure 7–11: Mitsubishi Tanabe Pharma Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 7–12: Mitsubishi Tanabe Pharma Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025
Figure 7–13: Emergent Biosolutions Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 7–14: Emergent Biosolutions Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025
Figure 7–15: Astlellas Pharma Inc Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 7–16: Astlellas Pharma Inc Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025
Figure 7–17: Valneva Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 7–18: Valneva Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025
Figure 7–19: Seqirus Vaccines Market Value Analysis (Million US$),2016 – 2018
Figure 7–20: Seqirus Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025
Figure 7–21: Bavarian Nordic Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 7–22: Bavarian Nordic Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025
Figure 7–23: Sinovac Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 7–24: Sinovac Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025
Figure 7–25: Panacea Biotec Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 7–26: Panacea Biotec Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025

  • Global Encephalitis Vaccination Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102
    According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......
  • Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......
  • Global Avian Influenza Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......
  • Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......
  • Global Influenza Vaccine Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......
  • Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......
  • 2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel
    Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107
    This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs